
-
抗体試薬
- フローサイトメトリー用試薬
-
ウェスタンブロッティング抗体試薬
- イムノアッセイ試薬
-
シングルセル試薬
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD® OMICS-One Protein Panels
-
細胞機能評価のための試薬
-
顕微鏡・イメージング用試薬
-
細胞調製・分離試薬
-
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD® OMICS-One Protein Panels
- Japan (Japanese)
-
Change country/language
Old Browser
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
シングルセル研究から得られる情報を最大限に活用
シングルセル研究から得られる情報を最大限に活用
マルチオミクス技術により、1回の実験で各細胞のさまざまな情報を得ることができ、シングルセルの研究が将来にわたって有効なものとなりました。BDのソリューションを使用することで、より多くの情報を得られ、高品質なデータを収集し、さらに多くの発見が期待できます。1細胞あたり1セント未満のコストで実現できます*。
It's time to harness the power of more.
↓この表は削除します
Features** | 10x Genomics | BD | Parse Biosciences or Scale Biosciences |
---|---|---|---|
High capital expenditure | Yes | No | N/A |
Sample loss | Clogging and wetting failures | None | Poor retrieval due to multiple pipetting steps |
Hands-on time | Moderate | Moderate | High |
Multiomics assays offered by same vendor | DNA (Epigenomics), RNA | DNA (Epigenomics), RNA, Protein | RNA |
Inter-user variability | Low, except for clogging and wetting failures | Low to none | Potentially high, due to multiple pipetting steps |
Fragile samples and granulocytes | Poor | Good capture and recovery | Poor |
Long-term stopping point during the workflow | <4 weeks | 1 year after cell capture on beads | <6months |
Partial use consumables | No | Yes | No |
Multiplet rate | High | Moderate | Low |
Choose
- Epigenomics Profiling
BD Rhapsody™ ATAC-Seq Assay
- Transcriptomics
BD Rhapsody™ Whole Transcriptome Amplification (WTA) Kits
- Genomics: Immune Profiling
BD Rhapsody™ TCR/BCR Next Multiomics Assay
- BD® OMICS-One Protein Panels (Protein Panels for CITE-Seq)
- Multiomics


Generate
BD Rhapsody™ HT Xpressシステムは、高額な設備投資や96ウェルプレートへの長時間のピペッティングを不要にし、再現性のある高品質なデータを1細胞あたり1セント未満で提供します*。
マイクロウェルカートリッジベースのシステムは、数百万の細胞を研究するために必要なハイスループットを実現します。

Analyze
- コーディングもバイオインフォマティシャンも必要なく、私たちの無償のデータ解析ソフトウェアは、複雑なデータを簡単に解析し、理解しやすい形で結果を得ることをサポートします。追加のサポートが必要な場合は、専門家チームにアクセスできます。
- BD Rhapsody™ Sequence Analysis Pipeline:わずか数クリックでシーケンシングの結果をマッピングし、実験のクオリティを確認するとともに、Visualization Toolで更なる解析を行うことができます。
- BD® Cellismo Data Visualization Tool :2025年3月にリリースされた最新の二次解析ソフトウェアを無償でご利用いただけます。簡単な操作でデータをわかりやすい図表に変換し、生物学的に重要な洞察を得ましょう。

最新ニュース
最新のeBookを読んで、シングルセル マルチオミクス、BD Rhapsody™ システム、およびセルソーティングが、がん免疫学の新しい発見や理解を深めるのにどのように役立つかをご確認ください。

The BD Rhapsody™ single-cell platform has been instrumental in advancing our translational research projects in inflammatory bowel disease (IBD) at Stanford. With the BD Rhapsody™ platform, we have been successful in robustly capturing traditionally difficult to isolate cell types (e.g. neutrophils) from intestinal biopsies. The platform has also enabled us to multiplex a large number of samples, capture significantly more cells, and perform advanced analyses combining whole transcriptomics with paired TCR and BCR sequencing.

The BD Rhapsody™ single-cell platform has been instrumental in advancing our translational research projects in inflammatory bowel disease (IBD) at Stanford. With the BD Rhapsody™ platform, we have been successful in robustly capturing traditionally difficult to isolate cell types (e.g. neutrophils) from intestinal biopsies. The platform has also enabled us to multiplex a large number of samples, capture significantly more cells, and perform advanced analyses combining whole transcriptomics with paired TCR and BCR sequencing.
The BD Rhapsody™ single-cell platform has been key for advancing our studies deciphering immunoregulatory networks in cancer and neglected diseases. We identified the cellular immune landscape using scarce human samples from tumors, lesions, and peripheral blood. We multiplexed four patient samples per cartridge using 10,000+ cells each to determine the activation state/functional potential of leukocytes in conjunction with their TCR or BCR variable region usage, thereby, allowing analysis of antigen specific responses with functional activity.

The BD Rhapsody™ single-cell platform has been key for advancing our studies deciphering immunoregulatory networks in cancer and neglected diseases. We identified the cellular immune landscape using scarce human samples from tumors, lesions, and peripheral blood. We multiplexed four patient samples per cartridge using 10,000+ cells each to determine the activation state/functional potential of leukocytes in conjunction with their TCR or BCR variable region usage, thereby, allowing analysis of antigen specific responses with functional activity.
The BD Rhapsody™ single-cell platform has been a key tool for the publication of our clinical research. It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention. After the analysis, we got very interesting information about the changes in genes that were up or downregulated before and after the intervention. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform.

The BD Rhapsody™ single-cell platform has been a key tool for the publication of our clinical research. It allowed us to study gene expression from immune populations of frozen PBMCs from people living with HIV after a nutritional intervention. After the analysis, we got very interesting information about the changes in genes that were up or downregulated before and after the intervention. These subtle changes would not have been discovered without the use of a powerful, highly sensitive technique such as the BD Rhapsody™ single-cell platform.
We prefer the Rhapsody™ system for single cell RNA-Seq on our samples as it allows us to see what we have loaded before committing to expensive downstream analysis. The imaging is also indispensable for visualizing rare cancer cells in our liquid biopsy applications, as it provides insight even before characterizing the multiomic profile.

We prefer the Rhapsody™ system for single cell RNA-Seq on our samples as it allows us to see what we have loaded before committing to expensive downstream analysis. The imaging is also indispensable for visualizing rare cancer cells in our liquid biopsy applications, as it provides insight even before characterizing the multiomic profile.
We as an early access user have adapted and rapidly expanded Rhapsody™ single cell multi-omics (WT, VDJ, AbSeq, and scATAC) services to a broad range of academic and industrial users. Our customers love BD Rhapsody™ 's super high capture capacity with multiplexing (SMK) approaches in the HT mode. It's robust, powerful, and cost-effective. The TCR/BCR Next works wonderfully as promised. The call rate of paired VDJ chains is superior to almost all other single cell platforms.

We as an early access user have adapted and rapidly expanded Rhapsody™ single cell multi-omics (WT, VDJ, AbSeq, and scATAC) services to a broad range of academic and industrial users. Our customers love BD Rhapsody™ 's super high capture capacity with multiplexing (SMK) approaches in the HT mode. It's robust, powerful, and cost-effective. The TCR/BCR Next works wonderfully as promised. The call rate of paired VDJ chains is superior to almost all other single cell platforms.
The BD Rhapsody™ single-cell platform is an innovative device that lowers the threshold for single-cell transcriptomic research. It is highly effective in studying multiple samples simultaneously due to its multiplexing efficiency, utilizing various antibodies developed by BD over time. Additionally, since it does not use microfluidics for cell separation, it avoids clogging issues, making it suitable for studying cells from precious tissue samples.

The BD Rhapsody™ single-cell platform is an innovative device that lowers the threshold for single-cell transcriptomic research. It is highly effective in studying multiple samples simultaneously due to its multiplexing efficiency, utilizing various antibodies developed by BD over time. Additionally, since it does not use microfluidics for cell separation, it avoids clogging issues, making it suitable for studying cells from precious tissue samples.
The BD Rhapsody™ System has become one of our lab's most important single-cell analysis tools. Its precision, efficiency, and scalability have enabled us to uncover insights across a range of hematological cancers and healthy hematopoiesis at unprecedented resolution. It excels in its ability to generate high-quality single-cell proteo-genomics data of several hundreds of surface markers alongside transcriptomics data. Its intuitive design and high reproducibility has undoubtedly accelerated our research and opened up new avenues for discovery.

The BD Rhapsody™ System has become one of our lab's most important single-cell analysis tools. Its precision, efficiency, and scalability have enabled us to uncover insights across a range of hematological cancers and healthy hematopoiesis at unprecedented resolution. It excels in its ability to generate high-quality single-cell proteo-genomics data of several hundreds of surface markers alongside transcriptomics data. Its intuitive design and high reproducibility has undoubtedly accelerated our research and opened up new avenues for discovery.


Schedule a Meeting
Want to learn more about our solution? Contact us now to connect with our Multiomics Specialists.
*Required fields
*1細胞あたりセントの計算には機器と試薬が含まれますが、シーケンス コストは含まれません。米国の価格から計算されています。
研究用です。本製品は、疾病の診断・治療または予防に使用することはできません。